Control of RNA processing by a large non-coding RNA over-expressed in carcinomas

FEBS Letters

Volumn 585, Issue 4, 2011, Pages 671-676

  Lin, Rui ^a   Roychowdhury Saha, Manami ^a   Black, Chris ^b   Watt, Andrew T ^b   Marcusson, Eric G ^b   Freier, Susan M ^b   Edgington, Thomas S ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b ISIS PHARMACEUTICALS   (United States)

Author keywords

RNA MALAT 1; Alternative splicing; Hepcarcin; RNA processing

Indexed keywords

HEPCARCIN; MALAT 1 PROTEIN; MESSENGER RNA PRECURSOR; RIBONUCLEOPROTEIN; SERINE ARGININE RICH PROTEIN; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; ENDOGLIN GENE; GENE; HELA CELL; HUMAN; HUMAN CELL; HYDROLYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA PROCESSING; TISSUE FACTOR GENE; TRANSCRIPTION REGULATION; UMBILICAL VEIN ENDOTHELIAL CELL;

ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD; CARCINOMA; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES, ANTISENSE; RATS; RECEPTORS, CELL SURFACE; RNA PRECURSORS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, NEOPLASM; RNA, UNTRANSLATED; RNA-BINDING PROTEINS; THROMBOPLASTIN;

EUKARYOTA; MURINAE;

EID: 79951580425     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.01.030     Document Type: Article

References (21)

1. J.P. Venables Aberrant and alternative splicing in cancer Cancer Res. 64 2004 7647 7654 (Pubitemid 39446889)
2. Y. Huang, and J.A. Steitz SRprises along a messenger's journey Mol. Cell 17 2005 613 615 (Pubitemid 40320911)
3. O. Rossbach, L.H. Hung, and S. Schreiner Auto- and crossregulation of the hnRNP L proteins by alternative splicing Mol. Cell. Biol. 29 2009 1442 1451
4. D.L. Black Mechanisms of alternative pre-messenger RNA splicing Annu. Rev. Biochem. 72 2003 291 336 (Pubitemid 36930448)
5. R. Lin, S. Maeda, C. Liu, M. Karin, and T.S. Edgington A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas Oncogene 26 2007 851 858
6. M. van Asseldonk, M. Schepens, D. de Bruijn, B. Janssen, G. Merkx, and A. Geurts van Kessel Construction of a 350-kb sequence-ready 11q13 cosmid contig encompassing the markers D11S4933 and D11S546:mapping of 11 genes and 3 tumor-associated translocation breakpoints Genomics 66 2000 35 42 (Pubitemid 30347169)
7. P. Ji, S. Diederichs, W. Wang, and S. Boing MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer Oncogene 22 2003 8031 8041 (Pubitemid 37175867)
8. J.N. Hutchinson, A.W. Ensminger, C.M. Clemson, C.R. Lynch, J.B. Lawrence, and A. Chess A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains BMC Genomics 8 2007 39
9. F. Guo, Y. Li, Y. Liu, J. Wang, Y. Li, and G. Li Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion Acta Biochim. Biophys. Sin. 42 2010 224 229
10. K. Tano MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes FEBS Lett. 584 2010 4575 4580
11. J.E. Wilusz, S.M. Freier, and D.L. Spector 3' End processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA Cell 135 2008 919 932
12. B.F. Baker 2'-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells J. Biol. Chem. 272 1997 11994 12000 (Pubitemid 27202775)
13. L.F. Lareau, M. Inada, R.E. Green, J.C. Wengrod, and S.E. Brenner Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements Nature 446 2007 926 929 (Pubitemid 46633161)
14. E. Fonsatti, L. Sigalotti, P. Arslan, M. Altomonte, and M. Maio Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies Curr. Cancer Drug Targets 3 2003 427 432 (Pubitemid 38017479)
15. N.A. Dallas Endoglin (CD105): a marker of tumor vasculature and potential target for therapy Clin. Cancer Res. 14 2008 1931 1937 (Pubitemid 351551101)
16. S. Velasco, P. Alvarez-Munoz, M. Pericacho, P.T. Dijke, C. Bernabeu, and J.M. Lopez-Novoa L- and S-endoglin differentially modulate TGFbeta1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts J. Cell Sci. 121 2008 913 919 (Pubitemid 351578127)
17. C. Milsom, and J. Rak Tissue factor and cancer Pathophysiol. Haemost. Thromb. 36 2008 160 176
18. S.A. Gregory, J.H. Morrissey, and T.S. Edgington Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin Mol. Cell. Biol. 9 1989 2752 2755 (Pubitemid 19148149)
19. N. Mackman, J.H. Morrissey, B. Fowler, and T.S. Edgington Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade Biochemistry 28 1989 1755 1762 (Pubitemid 19072050)
20. B. Szotowski, S. Antoniak, and U. Rauch Alternatively spliced tissue factor:a previously unknown piece in the puzzle of hemostasis Trends Cardiovasc. Med. 16 2006 177 182 (Pubitemid 43867331)
21. V. Tripathi The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation Mol. Cell 24 2010 925 938